In German media, Şahin said he was prompting research to develop a vaccine and gave the project the working title “Speed of Light”. Because, he says in interviews, everything had to run at record speed, at the speed of light. And so it happened.
As early as March, BioNTech has the basis for a candidate vaccine to be tested on laboratory animals. On March 17, a collaboration will be concluded with the American pharmaceutical company to further develop and test the vaccine.
–
Related posts:
The Osage Indian Tribe: Defying the Odds on America's Barren Plateau
The Impressive Subaru Solterra: A Coherent Electric Car Beyond Expectations
Gold prices surge to a one-year high of over $2,000 per ounce as banking sector worries resurface.
Interest rate cut brings sigh of relief in US mortgage market
